Related Experiment Video
Updated: Mar 25, 2026

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
Exploring Structural Perturbations Caused by Cancer-Related Mutations in Pyruvate Kinase M2: A Comparison with the
1Department of Chemistry, Indian Institute of Technology, Guwahati, Assam 781039, India.
Abstract:
One of the key glycolytic enzymes, pyruvate kinase (PKM2), is frequently found in mutated forms in cancer cells. While many have investigated the impact of the mutations on tumor size and progressions, their structural effects on the architecture of PKM2 have not been thoroughly studied. We examined 11 mutants using MD simulations and assessed their effects on structural dynamics, domain flexibility, and interaction networks. Among them, six mutants displayed significant perturbations compared to the WT, while five others retained WT-like behavior. RMSF and PCA demonstrated that mutations lead to destabilization of the B domain by disrupting its natural inward closure toward the A domain. Instead, they exhibited an outward or rotational movement, resulting in increased interdomain distances and a weakening of the native contacts between the A and B domains. Further analysis revealed that in the crucial region responsible for domain closure, there was a disruption of hydrogen bonds and salt bridges that are essential for stabilization. For the highly fluctuating mutants, R246S weakens the helical contacts to the hinge region, while K367 M and R399E compromise β-sheet pathways linked to the active and allosteric sites, P117L affects the anchor points in the hinge region, and R455Q and H464A destabilize the allosteric pockets by disrupting the connectivity between the helix, β-sheet, and the hinge. Collectively, these mutations impair communication with the domain closure region and suggest potential avenues for understanding cancer-related mutants.
Insights
Mutations in pyruvate kinase (PKM2) disrupt its structure, affecting cancer cell function. This study reveals how PKM2 mutations alter protein dynamics and interactions, offering insights into cancer development.
Area of Science:
- Biochemistry
- Structural Biology
- Cancer Biology
Background:
- Pyruvate kinase (PKM2) is a key glycolytic enzyme often mutated in cancer.
- Previous research focused on PKM2 mutations' impact on tumor growth, not structural changes.
- Understanding PKM2 structural dynamics is crucial for cancer research.
Purpose of the Study:
- To investigate the structural effects of PKM2 mutations on protein architecture.
- To analyze the impact of mutations on PKM2's dynamic behavior and interaction networks.
Main Methods:
- Molecular dynamics (MD) simulations were used to study 11 PKM2 mutants.
- Analysis included root-mean-square fluctuation (RMSF) and principal component analysis (PCA).
- Interactions, hydrogen bonds, and salt bridges were examined.
Main Results:
- Six of 11 PKM2 mutants showed significant structural perturbations compared to wild-type (WT).
- Mutations destabilized the B domain, disrupting its closure towards the A domain.
- Altered interdomain distances and weakened contacts were observed, impacting active and allosteric sites.
Conclusions:
- PKM2 mutations impair domain communication and structural stability.
- These findings provide insights into cancer-related PKM2 structural alterations.
- The study highlights potential therapeutic targets by understanding PKM2 mutant behavior.
Related Concept Videos
Abnormal Proliferation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

